Streetbeat News

Products Services

CAE

CAE USA has been awarded the U.S. Army’s Phase II rapid prototyping effort supporting the Soldier Virtual Trainer (SVT) program. The award follows a two-year selection process and is a 20-month effort to finalize the prototype of the Weapons Skills Development, the SVT Core computational system, and the Intelligent Tutor. The SVT program is part of the Program Executive Office for Simulation, Training and Instrumentation (PEO STRI) modernization effort to deliver a Synthetic Training Environment that will transform how the U.S. Army trains its soldiers.

Portfolio Pulse from Happy Mohamed

July 31, 2023 | 1:09 pm

DELL

NVDA

Dell Technologies has expanded its AI offerings with a new suite of products and services, in collaboration with NVIDIA, to accelerate secure generative AI initiatives. The new offerings include Dell Validated Design for Generative AI with NVIDIA, and expanded NVIDIA GPU configurations on Dell Precision workstations.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2023 | 1:07 pm

PNT

ITM and POINT Biopharma have expanded their global supply agreement for N.C.A. Lutetium-177. This expansion will allow for a more robust supply chain and increased production capabilities.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2023 | 1:05 pm

AMD

MU

NVDA

SSNLF

Nvidia continues to buy 'high bandwidth memory' (HBM) chips despite rising prices, contributing to a supply crisis for smaller market participants. SK Hynix and Samsung Electronics, who command 90% of the global HBM chip market, plan to double production despite losses due to supply glut. Nvidia and Advanced Micro Devices have requested samples of SK Hynix's next-generation HBM3E chips, indicating their importance in GPUs used in data centers and AI training. Micron Technology is sampling its HBM3 Gen 2 chip to close the gap with its Korean rivals.

Portfolio Pulse from Anusuya Lahiri

July 31, 2023 | 1:05 pm

MYMD

MyMD Pharmaceuticals has reported positive topline results from its Phase 2 study of oral TNF-α inhibitor, MYMD-1, in patients with chronic inflammation associated with sarcopenia, or age-related frailty. The study met its primary endpoints of significantly reducing chronic inflammatory markers in participants treated with MYMD-1. The company plans to present the data to the FDA and advance the clinical program for MYMD-1.

Portfolio Pulse from Happy Mohamed

July 31, 2023 | 1:01 pm

GWRE

Franklin Mutual Insurance Group has deployed Guidewire Cloud to increase business agility and deliver more value to agents and policyholders. This move is expected to support the insurer's growth strategy.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2023 | 12:59 pm

NVDA

Nvidia is expected to have a prosperous second half of the year due to a surge in demand for its artificial intelligence processors, according to industry sources.

Portfolio Pulse from Happy Mohamed

July 31, 2023 | 12:57 pm

LUMN

Lumen Technologies (NYSE:LUMN) has launched its Network-as-a-Service (NaaS) platform, offering customers flexibility in buying, using, and managing networking services. The first service added to the platform is Lumen Internet On-Demand. Over time, the platform will expand to include security services and Edge services. The platform's fully digital, consumption-based model is expected to set a new standard for customer experience. Lumen NaaS will leverage a broad digital ecosystem of partners, including Digital Realty, one of the first third-party data center providers to join the Lumen Network-as-a-Service Alliance Partner program.

Portfolio Pulse from Happy Mohamed

July 31, 2023 | 12:55 pm

GM

TSLA

VWAGY

Chinese firms are investing in South Korea's battery industry to gain exposure to the U.S. market. Over the past four months, Chinese and Korean companies have announced $4 billion of investments in five new battery factories in Korea. Chinese companies dominate the global battery supply chain, supplying to Korean EV cell manufacturers who, in turn, supply carmakers like General Motors Co, Tesla Inc, and Volkswagen AG. The Biden administration aims to reduce U.S. dependence on Chinese companies in the supply chain, but the deeply rooted presence of Chinese firms makes this problematic.

Portfolio Pulse from Anusuya Lahiri

July 31, 2023 | 12:49 pm

GTHX

GI Therapeutics has published real-world outcomes data showing that Trilaciclib reduces single and multilineage Grade ≥3 Myelosuppressive Hematologic Adverse Events (HAEs) in patients with extensive stage small cell lung cancer. The data also showed lower cytopenia-related healthcare utilization and all-cause hospitalization among patients receiving Trilaciclib.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2023 | 12:39 pm